John M. Lasala, MD, PhD, FACC
Current Position
Associate Professor, Medicine
Director, Interventional Cardiology
Medical Director, Cardiac Catheterization Lab
Specialty Areas
Cardiac Catheterization
Cardiology
Interventional Cardiology
Patients Seen At
|
Cardiac Catheterization Laboratory
One Barnes-Jewish Hospital
St. Louis,
MO
63110
314-362-2284
View Driving Directions
|
Areas of Clinical Interest
Cardiology, cardiac catheterizations, coronary artery disease, circulation, angioplasty, percutaneous transluminal coronary angioplasty (PTCA), myocardial infarction, coronary-artery stenting, Wolff-Parkinson White syndrome, ascending and descending aortic dissections, aortic aneurysms
Board Certification
Cardiology
--
Certified
Internal Medicine
--
Certified
Patients must be referred by a physician.
Medical Education
B.A.: Drew University, Madison, New Jersey, 1975
Ph.D.: St. Louis University, St. Louis, Missouri, 1979
Fellowship: Postdoctoral Anatomy and Neurobiology, Washington University School of Medicine, St. Louis, Missouri, 1979
Medical Degree: University Of Connecticut, Storrs, Connecticut, 1983
Residency: Internal Medicine, Barnes Hospital, Washington University School of Medicine, St. Louis, Missouri, 1986
Fellowship: Postdoctoral Cardiology, Yale University School of Medicine, New Haven, Connecticut, 1989
Fellowship: Intervential Cardiology, Yale University School of Medicine, New Haven, Connecticut, 1990
Hospital Affiliations
Barnes-Jewish Hospital
Major or Recent Publications/Awards
Honors and Awards
Listed in Best Doctors in America, 2003, 2005, 2006, 2010 (Best Doctors, Inc)
Disclosure of Financial Interests with IndustryWashington University and its physicians are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians work collaboratively with pharmaceutical or medical device companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our faculty physicians are paid by these commercial companies to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this web site, physicians earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.
Dr. John M. Lasala reported the following earned financial interests during calendar year 2009. Move your mouse over a header for more info.
| Company | Royalties Royalties: When a faculty member invents or conceives a new or improved process or product, the company that manufactures the product will make royalty payments to the faculty member. Royalty payments usually are a small percentage of the company’s revenue related to that product. | Consulting &
Advisory Boards Consulting and Advisory Boards: Faculty may be paid to provide expertise to a company by being their consultant, or by serving on an advisory board. | Speaker Fees Speaker Fees: Companies may pay faculty to speak to professional audiences about their products. |
| AGA Medical | | | $10K-25K |
| Boston Scientific | | $1K-$10K | $10K-25K |
| Bristol Meyers | | | $25K-50K |
| Eli Lilly | | | $50K-100K |
| Johnson & Johnson | | $10K-25K | $10K-25K |
To learn more about Washington University's policies on collaborations with industry,
click here.
Peer Reviewed Manuscripts
Walton BL, Mumm K, Taniuchi M, Kurz HI, Lasala JM. Diabetic patients treated with abciximab and intracoronary stenting. Catheter Cardiovasc Interv 2002; Mar;55(3):321-5
Goldstein JA, Beardslee MA, Xu H, Sundt TM, Lasala JM. Infective endocarditis resulting from CardioSEAL closure of a patent foramen ovale. Catheter Cardiovasc Interv 2002; Feb;55(2):217-20
Lasala JM. Stent thrombosis: it's never too late! Catheter Cardiovasc Interv 2002; Feb;55(2):148-9
Rinder MR, Tamirisa PK, Taniuchi M, Kurz HI, Mumm K, Lasala JM. Safety and efficacy of suture-mediated closure after percutaneous coronary interventions. Catheter Cardiovasc Interv 2001; Oct;54(2):146-51
Taniuchi M, Kurz HI, Lasala JM. Randomized comparison of ticlopidine and clopidogrel after intracoronary stent implantation in a broad patient population. Circulation 2001; Jul 31;104(5):539-43
Rinder MR, Lasala JM. Transcatheter closure of the atrial septum: it's been a long strange trip. Catheter Cardiovasc Interv 2001; Jul;53(3):378-9
Balm DS, Cutlip DE, Sharma SK, Lasala JM, et al. Final results of the balloon versus optimal artherectomy trial (BOAT). Circulation 1998; 4:322-331
Leon MB, Balm DS, Popma JJ, Stent Anticoagulation Restenosis Study Investigators, et al: A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. New England Journal of Medicine, 1998; 339:1665-1671
Smith SS, Taber M, Robiolio PR, Lasala JM. Acute myocardial infarction caused by a myocardial bridge treated with intracoronary stenting. Cathet Cardiovasc Diagn 1997; 42:209-212
Smith SS, Winters KJ, Lasala JM: Case Report - stent thrombosis in a patient receiving chemotherapy. Cathet Cardiovasc Diagn 1996; 40:383-386
Oltrona L, Eisenberg PR, Lasala JM, Sewell DJ, Shelton ME, Winters KJ: Association of heparin-resistant thrombin activity with acute ischemic complications of coronary interventions. Circulation 1996; 94:2064-2071
Invited Publications
Cleman MW, Lasala JM: Protected PTCA, In: Interventional Cardiology, E. Topol, ed, WB Saunders Publishing, 1992; 502-519
For more articles and abstracts, take this off-site link to the National Library of Medicine Pub Med page for Dr. John M. Lasala